Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC - a podcast by ReachMD

CME credits: 0.25

Valid until: 17-12-2022

Claim your CME credit at https://reachmd.com/programs/cme/keeping-pace-in-lung-cancer-applying-the-right-therapy-to-the-right-patient-in-ret-positive-nsclc/13130/

With an expanding arena of available selective RET inhibitors and more data being released on emerging therapies, the landscape for patients with RET-positive metastatic NSCLC is evolving rapidly. Join Drs. Mark Socinski and Justin Gainor as they review the importance of molecular testing in every patient, as well as when to initiate the use of selective RET-inhibitors across multiple lines of therapy. Did we mention you should be testing every patient? Tune in to make sure you’re identifying everyone who can benefit from these newer therapies.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD